Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Harmonization of TB.

Slides:



Advertisements
Similar presentations
Vertical versus Decentralized TB Pharmaceutical Management
Advertisements

Click to edit Master title style. Click to edit Master subtitle style.
Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level FERS ANNUITY SOCIAL SECURITY BENEFITS.
MEDICINES SELECTION & FORMULARY MANAGEMENT
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Diagnosis of TB.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
SECTION 5-4 Simple Interest pp
Paying Off Simple Interest Installment Loans pp SECTION.
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
SECTION 5-4 Simple Interest pp
“The causes of Anti-TB medicines shortages in EMR countries and how to avoid them in the future” Khaled Sultan Drug Management Technical Officer, STOP.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Revising the WHO TB Treatment Guidelines Process and new recommendations Malgosia Grzemska Matteo Zignol Stop TB Department World Health Organization DEWG.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
Overview of 2000 Survey of TB Drug Supply Experiences in Low- and Middle-Income WHO Member States Diana Weil Senior Public Health Specialist World Bank/United.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level Sustainable Development.
Certificates of Deposit pp SECTION.
Inventory Management: Distribution, ICS, LMIS Technical Briefing Seminar in Procurement and Supply Management for HIV, TB and Malaria Copenhagen, 1 February.
Principles and Structure of a Research Protocol Anthony Harries The Union, Paris, France.
Access to anti-TB medicines WHO/EDM Technical briefing seminar for international staff active in pharmaceutical support programmes Salle G, WHO HQ 30.
OHIO STATE UNIVERSITY EXTENSION TITLE SLIDE GOES HERE Optional subhead would go here OHIO AGRICULTURAL RESEARCH AND DEVELOPMENT CENTER.
Quantification from a TB Perspective PSM Workshop to Develop GFATM PSM plans for HIV, TB and Malaria February 2006, Nairobi.
Sales Tax pp SECTION. Click to edit Master text styles Second level Third level Fourth level Fifth level 2 SECTION Copyright © Glencoe/McGraw-Hill.
Paying Off Simple Interest Installment Loans pp SECTION.
The Monthly Payment pp SECTION. Click to edit Master text styles Second level Third level Fourth level Fifth level 2 SECTION Copyright ©
Biosimilar (Insulin) – Competitive Landscape and Market & Pipeline Analysis, 2016 DelveInsight’s, “Biosimilar (Insulin) – Competitive Landscape and Market. Request for sample of this research report:
Title of Presentation May Go Here Department Name Presentation for March 4, 2014 University Marketing.
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility.
Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Superintendent Search January 21, 2016.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Headline sample style Intro sample style Click to edit Master text styles –Second level Third level –Fourth level o Fifth level.
Click to Add Title Click to Add Subtitle.
Click to Add Title Click to Add Subtitle.
Click to edit Master text styles
Motivation and Background
Click to Add Title Click to Add Subtitle.
Click to Add Title Click to Add Subtitle.
Motivation and Background
Author names here Author association names here
Click to edit Master text styles
Insert Session Title of Up to Three Lines of Text and Information
Impact of Using Fixed Dose Combinations (FDCs) versus
Impact of Using Fixed Dose Combinations (FDCs) versus
Click to edit Master text styles
TITLE SLIDE GOES HERE Optional subhead.
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
INTRODUCTION OF FDCs: NTP POLICIES, INTERVENTIONS AND EXPERIENCE Shah S. K., Sadiq H., Ahmad N., Shaikh U & Kazi G. N. National TB Control Programme,
INTRODUCTION OF FDCs: NTP POLICIES, INTERVENTIONS AND EXPERIENCE Shah S. K., Sadiq H., Ahmad N., Shaikh U & Kazi G. N. National TB Control Programme,
Click to edit Master text styles
Slide Title Edit Master text styles Second level Third level
ОПШТЕСТВО ТЕМА: МЕСТОТО ВО КОЕ ЖИВЕАМ Скопје
Author names here Author associations here
Author names here Author associations here
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility
Global Drug Facility: Providing Access to Medicines and Commodities for Tuberculosis Thomas Moore Manager GDF Geneva, 19 November 2009.
Click to edit Master text styles
Lorem ipsum dolores Lorem ipsum dolores.
Presentation Title Presenter’s Name.
Author names here Author associations here
Click to edit Master text styles
Click to edit Master title style
Title Layout SUBTITLE. Title and Content Layout with List Click to edit Master text styles Second level Third level Fourth level Fifth level.
Presentation transcript:

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Harmonization of TB Drugs and Their Presentations Peter Evans Consultant Global Drug Facility

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Standardization 15/50

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH All programs standardize, but some allow decisions at different levels.

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Who Decides to Standardize?  Patient  Health worker  Health center  District  State  Country  Global program

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH The best level at which to standardize depends on the type of program and the advantages to be gained.

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Successful global programs standardize procedures and products as they accelerate. Or perhaps successful global programs accelerate as they standardize.

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH  Smallpox –Variable products, detection, administration, surveillance, and reporting  Leprosy –Variable products and administration Reflect A single set of products and processes used globally with predictable, measurable, reportable, amazing results

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Successful health programs have another important characteristic: They recognize that logistics and management are the key to achieving goals.

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Advantages of Standardization  Easier logistics –Available when needed –Know what you are getting  Higher quality –STOP TB standards, easier to control  More voice in the market –Larger orders may receive lower prices –Change specifications to match needs

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH  19 TB products for 6 drugs on the WHO Model Essential Drugs List (and many other products in use by national programs)  11 regimens approved by WHO in 3 treatment categories  2 recommended dosages, daily and intermittent  3 weight categories (not always consistent)  Variety of packaging: blisters, foil wrapped, loose tablets How is STOP TB doing in standardizing?

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH TB treatment category TB patientsTB treatment regimens Initial phaseContinuation phase Daily (28 doses/month) Daily (28 doses/month) 1New smear-positive patients; new smear-negative PTB with extensive parenchymal involvement; severe concomitant HIV disease or severe forms of extrapulmonary TB 2 (RHZE) = 56 doses of RHZE 4 (RH) = 112 doses of RH or 6 (HE) = 168 doses of HE 2Previously treated sputum smear-positive PTB: - relapse - treatment after interruption - treatment failure 2 (RHZE)S + 1 (RHZE) = 84 doses of RHZE plus 56 doses of S 5 (RH) E = 140 doses of RHE 3New smear-negative PTB (other than in Category 1) and less severe forms of extrapulmonary TB 2 (RH) Z = 56 doses of RHZ 4 (RH) = 112 doses of RH or 6 (HE) = 168 doses of HE TB Treatment Regimens by Treatment Category

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH TB treatment category TB patientsTB treatment regimens Initial phaseContinuation phase Daily (28 doses/month) 3 times per week (12 doses/month) Daily (28 doses/month) 3 times per week (12 doses/month) 1New smear-positive patients; new smear-negative PTB with extensive parenchymal involvement; severe concomitant HIV disease or severe forms of extrapulmonary TB 2 (RHZE) = 56 doses of RHZE 2 H 3 R 3 Z 3 E 3 = 24 doses of RHZE 4 (RH) = 112 doses of RH or 6 (HE) = 168 doses of HE 4 (RH) 3 = 48 doses of RH 2Previously treated sputum smear-positive PTB: - relapse - treatment after interruption - treatment failure 2 (RHZE)S + 1 (RHZE) = 84 doses of RHZE plus 56 doses of S 2 H 3 R 3 Z 3 E 3 S H 3 R 3 Z 3 E 3 = 36 doses of RHZE plus 24 doses of S 5 (RH) E = 140 doses of RHE 5 (RHE) 3 = 60 doses of RHE 3New smear-negative PTB (other than in Category 1) and less severe forms of extrapulmonary TB. 2 (RH) Z = 56 doses of RHZ 2 (RHZ) 3 = 24 doses of RHZ 4 (RH) = 112 doses of RH or 6 (HE) = 168 doses of HE 4 (RH) 3 = 48 doses of RH

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Congo Brazzaville Categories 1 & 3 (RHZE) 56 doses (RH) 112 doses Category 2 S + (RHZE) 56 doses (RHZE) 140 doses 3 products; suitable for all weights, all categories

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH India advantage One pack suits all –No weight differentiation Simplified dispensing system –One blister per visit, missing patients obvious Much lower cost per patient –World Bank Loan being returned Full treatment reserved for patient –Impact on private market Simplified ordering system

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Simplified ordering system Traditional system –Look up how many patients for each category have been treated since last order came, write this down, then... There are often several pages of considerations and calculations before the number of tablets and the number of containers are known and ready for ordering.

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH Simplified ordering system India system –Look up how many new patients, for each category, have been treated since last order came, write this down, then... That’s it. There is no next step. Can you imagine how simple stock control has just become?

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH GDF Work within WHO and IUATLD guidelines Adopt existing standards Consider the best of what is available Don’t try to be all things to all people Put the most effort into what will have the most impact High quality, low cost, meet program needs

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH GDF Limited list of products –Focus on (RHZE), (RH), (RH) 3,(HE), S Limited presentations – Focus on blister packing, suitable for patient packs Maximum quality –Testing and bioavailability standards followed Maximum service –Products always available when needed

Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level Stop TB KNCV MSH 50 Thank you.